Literature DB >> 6351733

Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.

A H Seeberg, R M Tolxdorff-Neutzling, B Wiedemann.   

Abstract

About 70% of all Enterobacter cloacae strains tested possessed one of two species-specific beta-lactamases. These enzymes, E. cloacae beta-lactamase A and E. cloacae beta-lactamase B, with isoelectric points of 8.8 and 7.8, respectively, had the same pH and temperature optima. Both showed similar enzyme kinetics and were inhibited by cloxacillin but not by p-chloromercuribenzoate. E. cloacae beta-lactamase B appeared to be identical with the enzyme of E. cloacae P99. By a mutation in a regulatory gene, inducible enzyme production could be converted into constitutive expression. In E. cloacae, both enzymes did not hydrolyze third-generation cephalosporins, but they were solely responsible for resistance toward these drugs. This was demonstrated by the characterization of Escherichia coli strains expressing an identical resistance pattern after transfer of the corresponding Enterobacter gene.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6351733      PMCID: PMC185004          DOI: 10.1128/AAC.23.6.918

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  23 in total

1.  Chromosome transfer and R-prime formation by an RP4::mini-Mu derivative in Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae, and Proteus mirabilis.

Authors:  F Van Gijsegem; A Toussaint
Journal:  Plasmid       Date:  1982-01       Impact factor: 3.466

2.  Resistance to cefamandole: derepression of beta-lactamases by cefoxitin and mutation in Enterobacter cloacae.

Authors:  T D Gootz; C C Sanders; R V Goering
Journal:  J Infect Dis       Date:  1982-07       Impact factor: 5.226

3.  Purification and properties of a cephalosporinase from Enterobacter cloacae.

Authors:  S Minami; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-12       Impact factor: 5.191

4.  The role of inducible beta-lactamases in the antagonism seen with certain cephalosporin combinations.

Authors:  K P Fu; H C Neu
Journal:  J Antimicrob Chemother       Date:  1981-01       Impact factor: 5.790

5.  Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae.

Authors:  S Minami; A Yotsuji; M Inoue; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1980-09       Impact factor: 5.191

Review 6.  Antibiotic resistance in pathogenic and producing bacteria, with special reference to beta-lactam antibiotics.

Authors:  H Ogawara
Journal:  Microbiol Rev       Date:  1981-12

Review 7.  beta-Lactamases and their clinical significance.

Authors:  J M Hamilton-Miller
Journal:  J Antimicrob Chemother       Date:  1982-02       Impact factor: 5.790

8.  Mutational enzymatic resistance of Enterobacter species to beta-lactam antibiotics.

Authors:  M F Lampe; B J Allan; B H Minshew; J C Sherris
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

9.  Common evolutionary origin of chromosomal beta-lactamase genes in enterobacteria.

Authors:  S Bergström; O Olsson; S Normark
Journal:  J Bacteriol       Date:  1982-05       Impact factor: 3.490

10.  Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism.

Authors:  R L Then; P Angehrn
Journal:  Antimicrob Agents Chemother       Date:  1982-05       Impact factor: 5.191

View more
  77 in total

1.  A new TEM-derived extended-spectrum beta-lactamase (TEM-91) with an R164C substitution at the omega-loop confers ceftazidime resistance.

Authors:  Hiroshi Kurokawa; Naohiro Shibata; Yohei Doi; Keigo Shibayama; Kazunari Kamachi; Tetsuya Yagi; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

2.  Discrimination of extended-spectrum beta-lactamases by a novel nitrocefin competition assay.

Authors:  G A Papanicolaou; A A Medeiros
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

3.  Cloning, sequencing and analysis of the structural gene and regulatory region of the Pseudomonas aeruginosa chromosomal ampC beta-lactamase.

Authors:  J M Lodge; S D Minchin; L J Piddock; S J Busby
Journal:  Biochem J       Date:  1990-12-15       Impact factor: 3.857

Review 4.  Class I beta-lactamases. Induction and derepression.

Authors:  I Phillips; K Shannon
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

Review 5.  Resistance to third generation cephalosporins: the current situation.

Authors:  J C Pechère
Journal:  Infection       Date:  1989 Sep-Oct       Impact factor: 3.553

Review 6.  Classification of beta-lactamases: groups 1, 2a, 2b, and 2b'.

Authors:  K Bush
Journal:  Antimicrob Agents Chemother       Date:  1989-03       Impact factor: 5.191

7.  Characterization of beta-lactamases from non-Bacteroides fragilis group Bacteroides spp. belonging to seven species and their role in beta-lactam resistance.

Authors:  P C Appelbaum; A Philippon; M R Jacobs; S K Spangler; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

8.  A survey of the kinetic parameters of class C beta-lactamases. Cephalosporins and other beta-lactam compounds.

Authors:  M Galleni; G Amicosante; J M Frère
Journal:  Biochem J       Date:  1988-10-01       Impact factor: 3.857

9.  Characterization of a novel plasmid-mediated cephalosporinase (CMY-9) and its genetic environment in an Escherichia coli clinical isolate.

Authors:  Yohei Doi; Naohiro Shibata; Keigo Shibayama; Kazunari Kamachi; Hiroshi Kurokawa; Keiko Yokoyama; Tetsuya Yagi; Yoshichika Arakawa
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

10.  Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.

Authors:  A Vuye; G Verschraegen; G Claeys
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.